DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/gzsjsl/handbook_of) has announced the addition of the "Handbook of Metastatic Breast Cancer" book to their offering.

About one third of women diagnosed with breast cancer will develop metastatic disease and subsequently die from their advanced breast cancer. Recent developments with novel systemic drugs, palliative surgical techniques and diagnostic imaging have given hope for the treatment of patients whose breast cancer has spread beyond its primary tumour.

Written by a team from leading cancer centres in Europe, including the UK's Royal Marsden Hospital, the Handbook of Metastatic Breast Cancer, Second Edition provides advanced scientific information and guidance on clinical problems associated with metastatic breast cancer.

Highlights of the Second Edition include:

- New chapters on specialist treatment options, gene expression signatures, biomarkers, and specialist support services for patients and their families

- Significant updates to chapters discussing systemic treatments for breast cancer, including endocrine therapy, chemotherapy, targeted therapies, and bisphosphonates

- Up-to-date information on diagnostic imaging and tumour assessment, including positron emission tomography and computed tomography

- Up-to-date information on local treatment options for neurological, thoracic, orthopaedic, and hepatic complications

This handbook will be a practical and comprehensive resource for medical and clinical oncologists, breast surgeons and radiologists, as well as neurosurgeons, clinical scientists, orthopaedic and thoracic surgeons.

Read more:
Research and Markets: Handbook of Metastatic Breast Cancer

Comments are closed.